Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lung Neoplasms 9Hematopoietic and Lymphatic System Neoplasm 7Prostatic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Urinary Bladder Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Ovarian Neoplasms 3Hematopoietic and Lymphoid System Neoplasm 3Hematologic Neoplasms 3Colorectal Neoplasms 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Mouth Neoplasms 2Melanoma 2Malignant Solid Neoplasm 2Head and Neck Carcinoma 2Fallopian Tube Neoplasms 2Vulvar Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Ureteral Neoplasms 1Tonsillar Neoplasms 1Tongue Neoplasms 1Teratoma 1Stomatitis 1Spondylitis, Ankylosing 1Psoriasis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 4Specimen Handling 3Cyclophosphamide 3Biopsy 3sodium-iodide symporter 2fludarabine 2cemiplimab 2alectinib 2X-Rays 2Stem Cell Transplantation 2Photons 2Nivolumab 2Ipilimumab 2Immunoglobulin G 2Disulfides 2CTLA-4 Antigen 2treosulfan 1sargramostim 1ruxolitinib 1repotrectinib 1duvelisib 1brigatinib 1belinostat 1Whole-Body Irradiation 1Vinblastine 1Suspensions 1Standard of Care 1Practice Guidelines as Topic 1Positron-Emission Tomography 1Mycophenolic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Lymphoma, Large-Cell, Anaplastic × Practice Guidelines as Topic × Clear all
NCT06724237 2026-05-15

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Eastern Cooperative Oncology Group

Phase 3 Recruiting
294 enrolled
Lymphoid

Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡